Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Assets (2020 - 2025)

Historic Assets for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $15.4 million.

  • Biofrontera's Assets fell 1674.77% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year decrease of 1674.77%. This contributed to the annual value of $22.1 million for FY2024, which is 2087.57% down from last year.
  • Per Biofrontera's latest filing, its Assets stood at $15.4 million for Q3 2025, which was down 1674.77% from $20.1 million recorded in Q2 2025.
  • Biofrontera's 5-year Assets high stood at $55.1 million for Q3 2022, and its period low was $15.4 million during Q3 2021.
  • In the last 5 years, Biofrontera's Assets had a median value of $26.3 million in 2023 and averaged $32.5 million.
  • As far as peak fluctuations go, Biofrontera's Assets surged by 25859.71% in 2022, and later tumbled by 4570.72% in 2024.
  • Over the past 5 years, Biofrontera's Assets (Quarter) stood at $53.2 million in 2021, then fell by 4.39% to $50.9 million in 2022, then plummeted by 45.11% to $27.9 million in 2023, then decreased by 20.88% to $22.1 million in 2024, then crashed by 30.25% to $15.4 million in 2025.
  • Its Assets stands at $15.4 million for Q3 2025, versus $20.1 million for Q2 2025 and $16.6 million for Q1 2025.